CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- 4 Open-market sale Chief Financial Officer sold 25,000 shares at $99.15 ($2,478,818)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Financial Officer sold 1,697 shares at $79.20 ($134,402)
- 4 Open-market sale 10% owner sold 1,000,000 shares at $79.85 ($79,850,000)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B7 Offering Prospectus
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market sale Chief Executive Officer sold 7,239 shares at $68.88 ($498,622)
- 4 Grant or award Director acquired 267 shares (grant or award)
- 4 Planned sale President sold 14,979 shares at an average $78.47 ($1,175,394)
Page 5 of 14 · 267 filings